Tuesday, November 20, 2007

Broncus Technologies Files For IPO

Mountain View-based Broncus Technologies, which is developing and commercializing minimally-invasive medical devices for emphysema and other lung diseases, said in a filing with the SEC today that it is looking to raise up to $86.25M in an IPO on the NASDAQ. The firm said that it is looking to trade as "LUNG" on the Nasdaq Global Market. The firm's IPO is being underwritten by Lehman Brothers, Bears Stearns & Co., Jeffries & Company, and RBC Capital Markets. The company is venture backed by HBM Partners AG, Abingworth Management Ltd., Menlo Ventures, Boston Scientific, and Sightline Partners.